Hospira Gemcitabine for Injection 2 g/vial

Страна: Австралія

мова: англійська

Джерело: Department of Health (Therapeutic Goods Administration)

Активний інгредієнт:

gemcitabine hydrochloride, Quantity: 45.54 mg/mL

Доступна з:

Hospira Australia Pty Ltd

ІПН (Міжнародна Ім'я):

Gemcitabine hydrochloride

Фармацевтична форма:

Injection

Склад:

Excipient Ingredients: mannitol; sodium acetate trihydrate; water for injections; hydrochloric acid; sodium hydroxide

Адміністрація маршрут:

Intravenous Infusion

Одиниць в упаковці:

1 x 100 mL

Клас:

Medicine Listed (Export Only)

Тип рецепту:

(S1) This Schedule is intentionally blank

Терапевтичні свідчення:

Gemcitabine for Injection, USP (gemcitabine hydrochloride) is indicated for the: treatment of patients with locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas to achieve a Clinical Benefit Response (a composite measure of clinical imporvement). Treatment of patients with locally advanced or metastatic non-small lung cancer (NSCLC) as either a single agent or in combination with Cisplatin. Treatment of patients with Stage IV (locally advanced or metastatic) transitional cell carcinoma (TCC) of the bladder in combination with Cisplatin. Treatment, in combination with Paclitaxel, of patients with inresectable, locally recurrent or metastatic breast cancer, who have good performance status and have relapsed following adjuvant anthracycline-based chemotherapy.

Огляд продуктів:

Visual Identification: A clear solution practically free from foreign particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store between 15-30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Статус Авторизація:

Listed (Export Only)

Дата Авторизація:

2009-08-06